Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6559 | 1400 | 42.4 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3225 | 1510 | MACROPHAGE MIGRATION INHIBITORY FACTOR//MIF//MACROPHAGE MIGRATION INHIBITORY FACTOR MIF |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MACROPHAGE MIGRATION INHIBITORY FACTOR | Author keyword | 505 | 78% | 24% | 338 |
2 | MIF | Author keyword | 206 | 62% | 15% | 213 |
3 | MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | Author keyword | 149 | 88% | 5% | 69 |
4 | CD74 | Author keyword | 24 | 45% | 3% | 39 |
5 | D DOPACHROME TAUTOMERASE | Author keyword | 21 | 90% | 1% | 9 |
6 | MIGRATION INHIBITORY FACTOR | Author keyword | 20 | 58% | 2% | 23 |
7 | ISO 1 | Author keyword | 18 | 89% | 1% | 8 |
8 | TAUTOMERASE ACTIVITY | Author keyword | 18 | 89% | 1% | 8 |
9 | MACROPHAGE MIGRATION INHIBITORY FACTORS | Author keyword | 15 | 77% | 1% | 10 |
10 | TAUTOMERASE | Author keyword | 14 | 64% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MACROPHAGE MIGRATION INHIBITORY FACTOR | 505 | 78% | 24% | 338 | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR |
2 | MIF | 206 | 62% | 15% | 213 | Search MIF | Search MIF |
3 | MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | 149 | 88% | 5% | 69 | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR+MIF | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR+MIF |
4 | CD74 | 24 | 45% | 3% | 39 | Search CD74 | Search CD74 |
5 | D DOPACHROME TAUTOMERASE | 21 | 90% | 1% | 9 | Search D+DOPACHROME+TAUTOMERASE | Search D+DOPACHROME+TAUTOMERASE |
6 | MIGRATION INHIBITORY FACTOR | 20 | 58% | 2% | 23 | Search MIGRATION+INHIBITORY+FACTOR | Search MIGRATION+INHIBITORY+FACTOR |
7 | ISO 1 | 18 | 89% | 1% | 8 | Search ISO+1 | Search ISO+1 |
8 | TAUTOMERASE ACTIVITY | 18 | 89% | 1% | 8 | Search TAUTOMERASE+ACTIVITY | Search TAUTOMERASE+ACTIVITY |
9 | MACROPHAGE MIGRATION INHIBITORY FACTORS | 15 | 77% | 1% | 10 | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTORS | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTORS |
10 | TAUTOMERASE | 14 | 64% | 1% | 14 | Search TAUTOMERASE | Search TAUTOMERASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR MIF | 1101 | 83% | 45% | 630 |
2 | MIF | 126 | 70% | 7% | 104 |
3 | REGULATORY ROLE | 99 | 39% | 14% | 202 |
4 | TAUTOMERASE ACTIVE SITE | 61 | 86% | 2% | 31 |
5 | PHENYLPYRUVATE TAUTOMERASE | 49 | 79% | 2% | 31 |
6 | PROINFLAMMATORY FUNCTION | 47 | 88% | 2% | 22 |
7 | FACTOR MIF GENE | 45 | 90% | 1% | 19 |
8 | RAT CRESCENTIC GLOMERULONEPHRITIS | 40 | 82% | 2% | 23 |
9 | MIGRATION INHIBITORY FACTOR | 40 | 16% | 16% | 225 |
10 | CYTOKINE MIF | 34 | 93% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Macrophage migration inhibitory factor: A regulator of innate immunity | 2003 | 628 | 112 | 86% |
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis | 2006 | 163 | 120 | 65% |
Targeting the heat shock protein 90: a rational way to inhibit macrophage migration inhibitory factor function in cancer | 2014 | 6 | 62 | 76% |
Inflammation and cancer: macrophage migration inhibitory factor (MIF)-the potential missing link | 2010 | 58 | 54 | 65% |
Role of MIF in Inflammation and Tumorigenesis | 2008 | 56 | 66 | 88% |
The Role of MIF in Type 1 and Type 2 Diabetes Mellitus | 2014 | 4 | 52 | 79% |
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family | 2012 | 14 | 110 | 94% |
Current developments of macrophage migration inhibitory factor (MIF) inhibitors | 2013 | 8 | 68 | 90% |
MIF as a disease target: ISO-I as a proof-of-concept therapeutic | 2011 | 23 | 162 | 77% |
The Role of Macrophage Inhibitory Factor in Tumorigenesis and Central Nervous System Tumors | 2009 | 38 | 65 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL NEUROBIOL FUNCT NEUROPROTE | 4 | 75% | 0.2% | 3 |
2 | CHAIR INTER IAL ENGN | 4 | 56% | 0.4% | 5 |
3 | IMMUNOENDOCRINOL REPROD PHYSIOL | 4 | 56% | 0.4% | 5 |
4 | BAXTER BIOMED | 3 | 100% | 0.2% | 3 |
5 | ANLYAN | 3 | 23% | 0.9% | 12 |
6 | MED PATHOL EPIDEMIOL PUBL HLTH | 3 | 60% | 0.2% | 3 |
7 | CNRSESA 5472 | 2 | 67% | 0.1% | 2 |
8 | UHS 46 | 2 | 67% | 0.1% | 2 |
9 | SPORTS MED JOINT RECONSTRUCT SURG | 2 | 18% | 0.7% | 10 |
10 | AUGUST LENZ STIFTUNG | 2 | 43% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000076212 | BIOCATALYTIC PROMISCUITY//4 OXALOCROTONATE TAUTOMERASE//TAUTOMERASE SUPERFAMILY |
2 | 0.0000043108 | SALMONELLA TYPHIMURIUM VAR COPENHAGEN//FANCY PIGEON//SERV MED AVIAIRE |
3 | 0.0000034046 | BIFUNCTIONAL PEPTIDE INHIBITOR//TYKESON MS//BATF2 |
4 | 0.0000023809 | POSTMENOPAUSAL SKIN//HORMONAL AGING//DERMATOL ANDROL VENEREOL |
5 | 0.0000018114 | INVARIANT CHAIN//HLA DM//ANTIGEN PROCESSING |
6 | 0.0000016683 | INFLAMMATORY DIS//NEPHROTOXIC NEPHRITIS//IMMUNOL IMM5 |
7 | 0.0000014478 | KL 6//KREBS VON DEN LUNGEN 6//BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUG |
8 | 0.0000014069 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1 POLYMORPHISM//REGULATED UPON ACTIVATION |
9 | 0.0000013265 | COP9 SIGNALOSOME//NEDD8//NEDDYLATION |
10 | 0.0000012850 | ADIPOSE TISSUE MACROPHAGES//OBES BIOL UNIT//OBESITY INDUCED INFLAMMATION |